For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality.

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

A major new study has shown that a group of drugs called GLP-1 receptor agonists offer strong protection for both the kidneys ...

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked with improved clinical outcomes compared with conventional therapies.

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...

Researchers conducted the ACHIEVE-1 trial to assess the effect of orfoglipron on glycemic control among patients with early-stage type 2 diabetes.

Harvard T.H. Chan School of Public Health suggests combining GLP-1 weight-loss medication with tailored nutrition and ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

A healthy fasting blood glucose level for a person without diabetes is roughly 70 milligrams per deciliter to 99 milligrams ...